CAU
NVRI icon

Caxton Associates (UK)’s Enviri NVRI Stock Holding History

Caxton Associates (UK)’s Portfolio NVRI Stock Details NVRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,597
Closed -$414K – 913
2025
Q3 		$414K Buy
+32,597
New +$337K 0.01% 489

Other funds holding NVRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $603M AUM 62.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Caxton Associates (UK)'s NVRI Position: Q4 2025 in Review

Caxton Associates (UK) sold out of Enviri (NVRI) in Q4 2025, closing a stake of 32,597 shares — an estimated $414K sold.

Caxton Associates (UK) first reported a position in NVRI in Q3 2025 and held it in 1 quarter. The position peaked at $414K in Q3 2025. 234 funds tracked by Wall St. Rank hold NVRI as of Q4 2025.

  • Caxton Associates (UK) reported no remaining Enviri position as of Q4 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 32,597 Enviri shares in Q4 2025, an estimated $414K.
  • Caxton Associates (UK) first reported a position in Enviri in Q3 2025 and held it in 1 quarter.
  • Caxton Associates (UK)'s Enviri position peaked at $414K in Q3 2025.
  • 234 funds tracked by Wall St. Rank held Enviri as of Q4 2025.

Based on Caxton Associates (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.